Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sand Hill Angels XVI is a California limited liability company that appears to be one of the deal-specific or pooled investment vehicles used by the Sand Hill Angels angel investor network. It is not an operating biotechnology, pharmaceutical, or healthcare company; rather, it functions as an investment entity associated with Sand Hill Angels' model of aggregating member investments through multi-class LLCs. Publicly available information indicates the entity was formed in 2016 and is listed as active in California. Because it is an investment vehicle rather than a drug developer or healthcare operator, it does not have a therapeutic pipeline, clinical stage, or product portfolio in the usual biotech sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sand Hill Angels XVI.